Advertisement

Loading...

Genscript Biotech Corporation

1548.HKHKSE
Healthcare
Biotechnology
HK$12.32
HK$1.37(12.51%)
Hong Kong Market is Open • 11:48

1548.HK News Today: Stay Updated with the Latest Genscript Biotech Corporation News in Real Time

Find 1548.HK news now at Meyka AI. Stay informed with the latest Genscript Biotech Corporation stocks updates, including price news, market analysis, and expert insights.

Jefferies Maintains Buy for CTMX (CytomX Therapeutics) March 18, 2026
📅 in about 3 hours

Jefferies Maintains Buy for CTMX (CytomX Therapeutics) March 18, 2026

Jefferies maintained Buy on CTMX March 18, 2026. Read CTMX analyst rating, $16 PT, and Meyka AI grade B+

Read more
Evercore ISI maintains negative on The Progressive Corporation (PGR) March 2026
📅 in 42 minutes

Evercore ISI maintains negative on The Progressive Corporation (PGR) March 2026

PGR analyst rating: Evercore ISI maintained a negative view on PGR on March 18, 2026

Read more
Barclays Maintains Overweight on Incyte (INCY) Mar 2026
📅 1 hour ago

Barclays Maintains Overweight on Incyte (INCY) Mar 2026

INCY analyst rating: Barclays maintained Overweight on Incyte in Mar 2026, implications for investors and price context

Read more
Jefferies Maintains Buy on AAR Corp. (AIR) March 24, 2026
📅 1 hour ago

Jefferies Maintains Buy on AAR Corp. (AIR) March 24, 2026

Jefferies maintains Buy on AAR Corp. (AIR); latest AIR analyst rating and $150 price target details

Read more
SpaceX Viewed as Crucial Test for Upcoming Mega IPOs
📅 9 hours ago

SpaceX Viewed as Crucial Test for Upcoming Mega IPOs

Space exploration and private investment are entering a new era as SpaceX increasingly becomes a central focus for future public offerings. Industry analysts now view SpaceX not just as a pioneer in rocket technology and satellite networks but also as a crucial test case for upcoming mega IPOs. The company’s potential stock market debut could…

Read more
BofA Unveils 10 US Stock Picks for Q2 as Market Pullback Creates Opportunities
📅 9 hours ago

BofA Unveils 10 US Stock Picks for Q2 as Market Pullback Creates Opportunities

As the US equity market experiences a mild pullback in early 2026, BofA analysts are highlighting opportunities for long‑term investors. BofA has released a new set of 10 recommended US stocks that it believes could benefit from current valuations and broader economic trends. These picks reflect strong fundamentals, sector growth potential, and positioning in future‑oriented…

Read more
Pre-market (02 Apr 2026) top loser: EM3.AX EMC Gold down 32% to A$0.17: monitor A$0.14 support
📅 10 hours ago

Pre-market (02 Apr 2026) top loser: EM3.AX EMC Gold down 32% to A$0.17: monitor A$0.14 support

EM3.AX stock falls 32% to A$0.17 pre-market on 02 Apr 2026; heavy volume and support at A$0.14

Read more
Pre-Market: AI.TO Atrium Mortgage Investment (TSX) C$11.54 01 Apr 2026: Forecast ahead
📅 11 hours ago

Pre-Market: AI.TO Atrium Mortgage Investment (TSX) C$11.54 01 Apr 2026: Forecast ahead

Pre-market look at AI.TO stock at C$11.54 on 01 Apr 2026. Valuation, Meyka forecast and risks for TSX investors

Read more
WMXCF stock down 99.5% on 01 Apr 2026 PNK: assess balance sheet risks
📅 12 hours ago

WMXCF stock down 99.5% on 01 Apr 2026 PNK: assess balance sheet risks

WMXCF stock falls 99.5% to USD 0.000001 on 01 Apr 2026; volume 399,458. Read Meyka AI grade, forecast and risks.

Read more

1548.HK News FAQ